Top Markets
#1 Black Phoenix Black Phoenix +360.62%
#2 Islamic Coin Islamic Coin +158.11%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.43%
#5 Akedo Akedo +47.69%
#6 BasedHype BasedHype +32.23%
#7 Acurast Acurast +28.01%
#8 Cryptopia Cryptopia +22.04%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Playnance Playnance +18.61%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rangering i aksjer #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aksjekurs
$0.0003
Sist synkronisert: 2023-06-13
Markedsverdi
$28.14K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Kategori

Healthcare
Inntekter for Neuropathix, Inc. (NPTX)
Inntekter i 2026 TTM: 0
Ifølge Neuropathix, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Neuropathix, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE